Following the Covid-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format

Bibliographic Data

ID15500985
AuthorsTal Schiller (0000-0002-8378-2903, Hebrew University of Jerusalem), Taiba Zornitzki (0000-0003-2601-1683, Hebrew University of Jerusalem), Viviana Ostrovsky (0000-0002-7847-7365, Hebrew University of Jerusalem), Danielle Sapojnik (Hebrew University of Jerusalem), Lee S Cohen (0000-0003-0489-1093, Hebrew University of Jerusalem), Lee Cohen (Hebrew University of Jerusalem), Tamila Kunyavski (Hebrew University of Jerusalem), Hilla Knobler (0000-0002-8125-7291, Hebrew University of Jerusalem), Alena Kirzhner (0000-0003-0457-432X, Hebrew University of Jerusalem, corresponding author)
Year2021
Volume18
Issue21
Pages11309-11309
Publication date2021-10-28
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph182111309
PMID34769826
OpenAlexW3210911794
LanguageEN
Citations received2
References cited23

Our data demonstrate that the COVID-19 experience has led to a growing interest of T1D patients in using the hybrid format of telemedicine. However, we still need to better understand who will benefit most from this platform and assess its cost-effectiveness and organization

Coronavirus disease 2019 (COVID-19 · Diabetes mellitus · Disease · Download · Family medicine · Health care · Medical emergency · MEDLINE · Pandemic · Preference · Telemedicine · Type 1 diabetes · World Wide Web · Computer Science · Diabetes Management and Education · Diabetes Management and Research · Medicine · Mobile Health and mHealth Applications · Internal Medicine

Tools

Open DOIOpen Access